Torsdag 17 September | 18:29:46 Europe / Stockholm
Est. tid*
2023-02-22 - Bokslutskommuniké 2022
2022-12-05 - Extra Bolagsstämma 2022
2022-07-21 - Kvartalsrapport 2022-Q2
2022-05-31 - Årsstämma
2022-05-06 - X-dag ordinarie utdelning KARO 0.00 SEK
2022-02-25 - Bokslutskommuniké 2021
2021-10-28 - Kvartalsrapport 2021-Q3
2021-07-22 - Kvartalsrapport 2021-Q2
2021-04-23 - X-dag ordinarie utdelning KARO 0.00 SEK
2021-04-21 - Årsstämma
2021-04-21 - Kvartalsrapport 2021-Q1
2021-02-18 - Bokslutskommuniké 2020
2020-10-30 - Kvartalsrapport 2020-Q3
2020-07-21 - Kvartalsrapport 2020-Q2
2020-05-25 - Årsstämma
2020-04-30 - X-dag ordinarie utdelning KARO 0.00 SEK
2020-04-29 - Kvartalsrapport 2020-Q1
2020-02-20 - Bokslutskommuniké 2019
2019-11-15 - Kvartalsrapport 2019-Q3
2019-09-20 - Extra Bolagsstämma 2019
2019-07-19 - Kvartalsrapport 2019-Q2
2019-05-17 - X-dag ordinarie utdelning KARO 0.00 SEK
2019-05-16 - Årsstämma
2019-04-26 - Kvartalsrapport 2019-Q1
2019-02-14 - Bokslutskommuniké 2018
2018-11-01 - Kvartalsrapport 2018-Q3
2018-07-19 - Kvartalsrapport 2018-Q2
2018-05-04 - X-dag ordinarie utdelning KARO 0.30 SEK
2018-05-03 - Årsstämma
2018-04-26 - Kvartalsrapport 2018-Q1
2018-02-22 - Bokslutskommuniké 2017
2017-12-08 - Extra Bolagsstämma 2017
2017-11-02 - Kvartalsrapport 2017-Q3
2017-08-24 - Kvartalsrapport 2017-Q2
2017-05-12 - X-dag ordinarie utdelning KARO 0.28 SEK
2017-05-12 - X-dag bonusutdelning KARO 0.22
2017-05-11 - Årsstämma
2017-05-10 - Kvartalsrapport 2017-Q1
2017-02-28 - Bokslutskommuniké 2016
2016-10-27 - Kvartalsrapport 2016-Q3
2016-07-15 - Kvartalsrapport 2016-Q2
2016-05-13 - X-dag ordinarie utdelning KARO 0.00 SEK
2016-05-12 - Årsstämma
2016-05-12 - Kvartalsrapport 2016-Q1
2016-03-16 - Extra Bolagsstämma 2016
2016-02-12 - Bokslutskommuniké 2015
2015-10-29 - Kvartalsrapport 2015-Q3
2015-08-26 - Split KARO 20:1
2015-07-10 - Kvartalsrapport 2015-Q2
2015-04-30 - X-dag ordinarie utdelning KARO 0.00 SEK
2015-04-29 - Årsstämma
2015-04-29 - Kvartalsrapport 2015-Q1
2015-02-13 - Bokslutskommuniké 2014
2014-10-29 - Kvartalsrapport 2014-Q3
2014-07-11 - Kvartalsrapport 2014-Q2
2014-05-09 - X-dag ordinarie utdelning KARO 0.00 SEK
2014-05-08 - Årsstämma
2014-05-08 - Kvartalsrapport 2014-Q1
2014-03-17 - Extra Bolagsstämma 2014
2014-02-13 - Bokslutskommuniké 2013
2013-10-25 - Kvartalsrapport 2013-Q3
2013-07-12 - Kvartalsrapport 2013-Q2
2013-05-08 - X-dag ordinarie utdelning KARO 0.00 SEK
2013-05-07 - Årsstämma
2013-05-07 - Kvartalsrapport 2013-Q1
2013-03-13 - 15-7 2013
2013-02-12 - Analytiker möte 2013
2013-02-12 - Bokslutskommuniké 2012
2012-11-19 - Extra Bolagsstämma 2012
2012-10-24 - Kvartalsrapport 2012-Q3
2012-07-13 - Kvartalsrapport 2012-Q2
2012-06-12 - Årsstämma
2012-04-30 - X-dag ordinarie utdelning KARO 0.00 SEK
2012-04-27 - Kvartalsrapport 2012-Q1
2012-02-08 - Bokslutskommuniké 2011
2011-11-29 - 15-7 2011
2011-10-25 - Kvartalsrapport 2011-Q3
2011-07-13 - Kvartalsrapport 2011-Q2
2011-04-28 - X-dag ordinarie utdelning KARO 0.00 SEK
2011-04-27 - Årsstämma
2011-04-27 - Kvartalsrapport 2011-Q1
2011-02-09 - Bokslutskommuniké 2010
2010-10-26 - Kvartalsrapport 2010-Q3
2010-07-13 - Kvartalsrapport 2010-Q2
2010-04-26 - X-dag ordinarie utdelning KARO 0.00 SEK
2010-04-23 - Årsstämma
2010-04-22 - Kvartalsrapport 2010-Q1
2010-02-09 - Bokslutskommuniké 2009
2009-10-22 - Kvartalsrapport 2009-Q3
2009-07-14 - Kvartalsrapport 2009-Q2
2009-04-27 - X-dag ordinarie utdelning KARO 0.00 SEK
2009-04-24 - Årsstämma
2009-04-22 - Kvartalsrapport 2009-Q1
LandSverige
SektorHälsovård
IndustriLäkemedel & Handel
Karo Pharma verkar inom vardagshälsa. Bolaget äger och kommersialiserar receptbelagda läkemedel och receptfria konsumentprodukter som säljs i apotek och detaljhandel samt via online-kanaler. Genom direkta försäljningsorganisationer och distributörsnätverk är bolagets produkter tillgängliga globalt, men med dess kärnverksamhet i Europa. Bolaget har sitt huvudkontor i Stockholm.

Analysera bolaget i Börsdata!

All ägardata du vill ha finns i Holdings!

Karo Healthcare appoints Philip Hampden-Smith as Chief Operations Officer

2026-08-26 14:00:00

Karo Healthcare ("Karo") has appointed Philip Hampden-Smith as Chief Operations Officer and member of the Corporate Management Team.

 

Philip brings 20 years of international experience in operations and supply chain leadership across consumer health, FMCG and pharmaceuticals. He joins Karo from Reckitt, where he most recently served as SVP Supply, North America, following a number of senior global and regional leadership roles.

 

During his long tenure at Reckitt, Philip has led large and complex supply organisations across multiple markets and built a strong track record in operational transformation, service improvement, cost reduction and M&A integration. He brings broad international experience and a proven ability to build scalable operations that support growth.

 

"We are very pleased to have attracted Philip to Karo. He brings extensive international operations experience and a strong track record of leading complex supply organisations. He is innovative and has a proven ability to drive performance and transformation against ambitious benchmarks. His experience will be highly valuable as we continue to strengthen our capabilities and refine and improve our operating model to deliver continued profitable growth,"  says Christoffer Lorenzen, CEO.

 

"Karo has a strong portfolio, a clear strategic direction and significant opportunities ahead. I believe in building high-performing operations that improve service, simplify ways of working and create sustainable value. I look forward to working with teams across Karo to build on what is already in place and strengthen the platform for the future. I'm delighted to be joining Karo at such an exciting stage in its development," says Philip Hampden-Smith.

 

Philip will take over from Jonathan Kimber, who leaves Karo after ten years with the Karo organisation. During his tenure, Jonathan has been instrumental in building Karo's Operations function and supporting the company's M&A journey, playing a key role in integrating acquired businesses and realising synergies through technology transfers. We thank Jonathan for his significant contributions to Karo and wish him every success in the future.

 

Philip will assume his role at Karo in Q4 2026.

 

For further information, please contact:

Lisa Westerdahl, Chief People & Sustainability Officer, lisa.westerdahl@karo.com

 

The information was submitted for publication by the contact person set out above, at 14:00 CET on 26 August 2026.

 

About Karo Healthcare

Karo Healthcare is a leading European consumer healthcare company with the purpose of delivering "Smart choices for everyday healthcare", empowering people to live life to the fullest. Our products are available in more than 90 countries and include trusted original brands such as Lamisil®, E45®, Pevaryl®, Proct®, Nutravita, Flux®, Multi-Gyn® and Paracet®. Headquartered in Stockholm, Karo employs about 600 people who work out of Karo's 13 international hubs. For more info, visit karohealthcare.com.